Sage Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/13/2024 | 5.76 M | $41.59 M | -10.22% | 9.43% |
| RTW INVESTMENTS, LP | 11/14/2024 | 5.59 M | $40.37 M | 2.03% | 9.15% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 5.39 M | $38.92 M | 100.00% | 8.82% |
| FMR LLC | 11/13/2024 | 5.27 M | $38.06 M | -9.48% | 8.62% |
| BELLEVUE GROUP AG | 11/14/2024 | 4.46 M | $32.21 M | -0.09% | 7.30% |
| STATE STREET CORP | 11/14/2024 | 2.93 M | $21.13 M | 18.24% | 4.79% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 1.50 M | $10.82 M | 541.48% | 2.45% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 1.26 M | $9.10 M | -11.60% | 2.06% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.24 M | $8.98 M | 0.30% | 2.03% |
| PALO ALTO INVESTORS LP | 11/14/2024 | 1.01 M | $7.30 M | 0.00% | 1.65% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 946,840 | $6.83 M | 161,476.79% | 1.55% |
| MORGAN STANLEY | 11/14/2024 | 808,798 | $5.84 M | -41.84% | 1.32% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 770,321 | $5.56 M | 2.50% | 1.26% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 671,950 | $4.85 M | 31.53% | 1.10% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 647,032 | $4.67 M | 99.53% | 1.06% |
| JEFFERIES FINANCIAL GROUP INC. | 11/14/2024 | 622,473 | $4.49 M | 113.08% | 1.02% |
| CITADEL ADVISORS LLC | 11/14/2024 | 609,502 | $4.40 M | 30.35% | 1.00% |
| 683 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 600,000 | $4.33 M | 20.00% | 0.98% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 513,300 | $3.71 M | -7.25% | 0.84% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 489,334 | $3.53 M | -3.93% | 0.80% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 452,193 | $3.26 M | 10.68% | 0.74% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 450,637 | $3.25 M | -12.13% | 0.74% |
| FISHER ASSET MANAGEMENT, LLC | 11/12/2024 | 432,545 | $3.12 M | -0.89% | 0.71% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 403,753 | $2.92 M | 330.30% | 0.66% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 11/13/2024 | 345,000 | $2.49 M | 18.68% | 0.56% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 332,612 | $2.40 M | 5.15% | 0.54% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 322,935 | $2.33 M | -24.87% | 0.53% |
| JANE STREET GROUP, LLC | 11/15/2024 | 227,476 | $1.64 M | -8.29% | 0.37% |
| WALLEYE CAPITAL LLC | 11/14/2024 | 220,973 | $1.60 M | 71.64% | 0.36% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 213,980 | $1.54 M | -22.09% | 0.35% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 186,039 | $1.34 M | 11.25% | 0.30% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 181,099 | $1.31 M | -17.21% | 0.30% |
| TREXQUANT INVESTMENT LP | 11/12/2024 | 175,661 | $1.27 M | -44.28% | 0.29% |
| HRT FINANCIAL LP | 11/12/2024 | 172,051 | $1.24 M | 44.18% | 0.28% |
| PDT PARTNERS, LLC | 11/14/2024 | 171,293 | $1.24 M | -26.69% | 0.28% |
| PINNACLE ASSOCIATES LTD | 10/25/2024 | 168,573 | $3.65 M | -42.52% | 0.28% |
| UBS GROUP AG | 11/14/2024 | 167,436 | $1.21 M | 19.97% | 0.27% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 165,190 | $1.19 M | -29.41% | 0.27% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 161,796 | $1.17 M | -23.99% | 0.26% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 161,700 | $1.17 M | 59.78% | 0.26% |
| COWEN AND COMPANY, LLC | 11/12/2024 | 161,186 | $1.16 M | -24.76% | 0.26% |
| JPMORGAN CHASE & CO | 12/26/2024 | 150,823 | $1.09 M | -87.43% | 0.25% |
| RAFFERTY ASSET MANAGEMENT, LLC | 11/13/2024 | 149,114 | $1.08 M | 20.98% | 0.24% |
| ALGERT GLOBAL LLC | 11/12/2024 | 143,034 | $1.03 M | 120.58% | 0.23% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 142,694 | $1.03 M | 0.00% | 0.23% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 141,936 | $1.02 M | -54.71% | 0.23% |
| VERITION FUND MANAGEMENT LLC | 11/14/2024 | 136,422 | $984,967 | -0.86% | 0.22% |
| BARCLAYS PLC | 11/19/2024 | 127,789 | $923,000 | 62.54% | 0.21% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 121,316 | $875,900 | 76.45% | 0.20% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 120,399 | $869,281 | -20.05% | 0.20% |
Sage Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 282 institutional investors and hedge funds held shares of Sage Therapeutics, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 5.76 M
RTW INVESTMENTS, LP: 5.59 M
BlackRock Funding, Inc. /DE: 5.39 M
FMR LLC: 5.27 M
Bellevue Group AG: 4.46 M
STATE STREET CORP: 2.93 M
84.15% of Sage Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 70.76 M shares in the last 24 months. This purchase volume represents approximately $409.69 M in transactions.